top of page
Drug Pricing & Affordability


PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement
PDABs say they’re helping patients. In reality, they’re muzzling public input and playing politics with life-saving medications.
Travis Manint
7 days ago6 min read
0 comments


HIV Long-Acting Injectables Face Policy Hurdles After CROI 2025
One shot a year could transform HIV care. But unless we fix access and policy, these breakthroughs won’t reach those who need them most.
Travis Manint
Mar 176 min read
0 comments


Patients Still at Risk: The State of Copay Accumulator Adjustment Policies in 2025
Copay accumulator policies make patients pay twice. It's 2025, and insurers are still profiting while patients go broke.
Travis Manint
Mar 107 min read
0 comments


Healthcare in the Lame Duck
Congress faces urgent healthcare decisions before 2025—telehealth, CHC funding, and physician payments hang in the balance during lame duck.
Travis Manint
Dec 8, 202410 min read
0 comments
bottom of page